7-38978015-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_001370959.1(POU6F2):c.62C>G(p.Ser21Ter) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 32)
Consequence
POU6F2
NM_001370959.1 stop_gained
NM_001370959.1 stop_gained
Scores
2
Clinical Significance
Conservation
PhyloP100: 5.69
Genes affected
POU6F2 (HGNC:21694): (POU class 6 homeobox 2) This gene encodes a member of the POU protein family characterized by the presence of a bipartite DNA binding domain, consisting of a POU-specific domain and a homeodomain, separated by a variable polylinker. The DNA binding domain may bind to DNA as monomers or as homo- and/or heterodimers, in a sequence-specific manner. The POU family members are transcriptional regulators, many of which are known to control cell type-specific differentiation pathways. This gene is a tumor suppressor involved in Wilms tumor (WT) predisposition. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-38978015-C-G is Pathogenic according to our data. Variant chr7-38978015-C-G is described in ClinVar as [Pathogenic]. Clinvar id is 1872.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POU6F2 | NM_001370959.1 | c.62C>G | p.Ser21Ter | stop_gained | 1/10 | ENST00000518318.7 | |
POU6F2 | NM_001166018.2 | c.-137C>G | 5_prime_UTR_variant | 1/11 | |||
POU6F2 | NM_007252.4 | c.-137C>G | 5_prime_UTR_variant | 1/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POU6F2 | ENST00000518318.7 | c.62C>G | p.Ser21Ter | stop_gained | 1/10 | 1 | NM_001370959.1 | P2 | |
POU6F2 | ENST00000403058.6 | c.-137C>G | 5_prime_UTR_variant | 1/11 | 5 | A2 | |||
POU6F2 | ENST00000673891.1 | c.62C>G | p.Ser21Ter | stop_gained, NMD_transcript_variant | 1/11 | ||||
POU6F2 | ENST00000674059.1 | c.62C>G | p.Ser21Ter | stop_gained, NMD_transcript_variant | 1/11 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Wilms tumor 5 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2004 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.